New multidrug regimen with indigenous drugs and dapsone in the treatment of lepromatous leprosy (preliminary report).

Sonali Chaudhury(Northwestern University), V Majumder, Sneegdha Poddar, Panna Das, Subrata Hazra, Sukanya Sarkar(Indian Institute of Chemical Biology), Goutam Podder(International Centre for Diarrhoeal Disease Research)

PubMed

July 1, 1987

Cited by 3

Related Papers

Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients

|Transplantation and Cellular Therapy|2013|248

Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of One Cohort from the Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)

|Transplantation and Cellular Therapy|2012|201

A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host Disease

|Transplantation and Cellular Therapy|2020|201

Prevalence of G2P[4] and G12P[6] Rotavirus, Bangladesh

|Emerging infectious diseases|2007|186

Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy

|Transplantation and Cellular Therapy|2021|183